Henri Kagan, Kenso Soai win chemistry Nobel for ‘mirror image’ breakthrough
Scientists honoured for solving mystery of asymmetric molecules that has helped in manufacture of pharmaceuticals.
This website’s original language is English. For translation, click the globe icon or choose Translate in the menu.
9 matching records found
Scientists honoured for solving mystery of asymmetric molecules that has helped in manufacture of pharmaceuticals.
Over the year, investigative agencies have busted nine big drug rackets involving counterfeit and adulterated pharmaceuticals, from cancer treatments and vaccines to antibiotics and psychotropic medicines
Hong Kong can attract more global biotech investments if the city builds up a new healthcare financial model, according to AstraZeneca, a Cambridge-based multinational pharmaceutical giant. While global drug makers have been doubling down on investments in mainland China in recent years, AstraZeneca brought over 60 clinical trials to the city and invested over HK$200 million (US$25.5 million) over the past three years. Hong Kong was still a key research and development hub for the firm, David...
Eligible products for the zero per cent tariff rate include all drugs designated for rare diseases, infertility treatments, cell therapies, gene therapies, antibody-drug conjugates (ADCs), and animal pharmaceuticals. Components of these drugs are also subject to a zero per cent tariff rate
The seizure has brought under scrutiny the alleged practice of repacking lower-cost medicines and relabelling them as expensive products, including carrying the labels of multinational pharmaceutical companies
India’s low medication prices are tied to its role as a major pharmaceutical exporter, supported by legislation that prevents ‘patent evergreening’ and enables generic drug manufacturing, says a study by diabetologists
China has set its sights on becoming a global biomedicine powerhouse by 2030, targeting key technological breakthroughs and at least a quarter of the world’s first-in-class drugs market under a new five-year plan for the sector. By the end of the decade, China would “firmly rank at the global forefront” in biopharmaceutical research and development and applications, with its “core competitiveness” and international influence making a significant leap, authorities said on Friday. The biomedical...
Big Pharma is betting on China for its next blockbuster drugs — what that shift means for patients and the future of US biotech dominance. (Source: Bloomberg)
Novartis AG shareholder Artisan Partners said the Swiss drugmaker needs to shake up its board and improve dealmaking after its shares plunged following three major clinical trial setbacks, Reuters reported.